In Brazilian patients, mutational frequency of driver genes was reported in a large number of lung adenocarcinoma cases (n = 444), with EGFR mutated in 22.7% and K-RAS in 20.4% of the cases [9]. This evidence concerns the gene KRAS and lung adenocarcinoma.